While Dr Reddy s recorded its highest-ever quarterly revenue in Q3, most of the growth was fueled by a higher-than-expected contribution from cancer drug Revlimid while the base US and India business delivered a subpar performance.
Aditya Birla Fashion & Retail has seen a nice breakout of consolidation and maintained upward sloping support trendline. The stock formed strong bullish candlestick pattern on the daily charts with healthy volumes.
In today s edition of Moneycontrol Pro Panorama: Ayodhya impact on general elections in the South, new budget schemes can unlock tourism potential, Middle-East is now a powder keg waiting to explode, budget allotment for science to make a big bang, and more